Sutro Biopharma, Inc.: Form 8-K, filed Dec 27, 2021
Filed with the SEC on Dec 27, 2021 and accepted by EDGAR at Dec 27, 2021, 07:00 ET.
Items reported
- Item 1.01 Entry into a material agreement
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-21-005353. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.